Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Datavault AI Inc. stock logo
DVLT
Datavault AI
$0.28
-5.8%
$0.34
$0.25
$4.10
$282.26M0.3144.80 million shs28.83 million shs
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
$0.00
+16.7%
$0.00
$0.00
$0.46
$586K0.6824.49 million shs17.85 million shs
Scilex Holding Company stock logo
SCLX
Scilex
$5.43
-2.5%
$7.20
$4.20
$34.27
$47.31M1.6748,826 shs46,669 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Datavault AI Inc. stock logo
DVLT
Datavault AI
+1.71%-5.68%-9.39%-40.56%-30.02%
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
+16.67%+16.67%-12.50%-56.25%-99.66%
Scilex Holding Company stock logo
SCLX
Scilex
-0.71%-3.97%-18.33%-37.42%-69.09%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Datavault AI Inc. stock logo
DVLT
Datavault AI
$0.28
-5.8%
$0.34
$0.25
$4.10
$282.26M0.3144.80 million shs28.83 million shs
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
$0.00
+16.7%
$0.00
$0.00
$0.46
$586K0.6824.49 million shs17.85 million shs
Scilex Holding Company stock logo
SCLX
Scilex
$5.43
-2.5%
$7.20
$4.20
$34.27
$47.31M1.6748,826 shs46,669 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Datavault AI Inc. stock logo
DVLT
Datavault AI
+1.71%-5.68%-9.39%-40.56%-30.02%
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
+16.67%+16.67%-12.50%-56.25%-99.66%
Scilex Holding Company stock logo
SCLX
Scilex
-0.71%-3.97%-18.33%-37.42%-69.09%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Datavault AI Inc. stock logo
DVLT
Datavault AI
2.50
Moderate Buy$2.50792.86% Upside
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
0.00
N/AN/AN/A
Scilex Holding Company stock logo
SCLX
Scilex
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest SCLX, NMHI, and DVLT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/10/2026
Datavault AI Inc. stock logo
DVLT
Datavault AI
UpgradeHold
8/5/2026
Datavault AI Inc. stock logo
DVLT
Datavault AI
Initiated CoverageBuy$2.00
8/4/2026
Datavault AI Inc. stock logo
DVLT
Datavault AI
UpgradeStrong-Buy
7/21/2026
Datavault AI Inc. stock logo
DVLT
Datavault AI
Reiterated RatingSell (E+)
6/16/2026
Scilex Holding Company stock logo
SCLX
Scilex
Reiterated RatingSell (E+)
(Data available from 8/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Datavault AI Inc. stock logo
DVLT
Datavault AI
$39.09M6.80N/AN/A$0.26 per share1.08
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
$9.99M0.06N/AN/A($9.06) per share0.00
Scilex Holding Company stock logo
SCLX
Scilex
$31.61M1.46N/AN/A($36.56) per share-0.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Datavault AI Inc. stock logo
DVLT
Datavault AI
-$78.99M-$0.42N/A2.00N/A-370.21%-46.04%-39.35%N/A
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
-$7.34M-$0.47N/AN/AN/A-127.93%N/A-95.86%N/A
Scilex Holding Company stock logo
SCLX
Scilex
-$358.73M-$49.70N/AN/AN/A-1,414.57%N/A-147.00%9/2/2026 (Estimated)

Latest SCLX, NMHI, and DVLT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/2/2026Q2 2026
Scilex Holding Company stock logo
SCLX
Scilex
-$0.1813N/AN/AN/A$16.00 millionN/A
8/14/2026Q2 2026
Scilex Holding Company stock logo
SCLX
Scilex
-$0.1813-$16.65-$16.4687-$16.65$16.00 million$7.64 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Datavault AI Inc. stock logo
DVLT
Datavault AI
N/AN/AN/AN/AN/A
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
N/AN/AN/AN/AN/A
Scilex Holding Company stock logo
SCLX
Scilex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Datavault AI Inc. stock logo
DVLT
Datavault AI
N/A
4.95
4.92
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
N/A
0.41
0.24
Scilex Holding Company stock logo
SCLX
Scilex
N/A
0.07
0.06

Institutional Ownership

CompanyInstitutional Ownership
Datavault AI Inc. stock logo
DVLT
Datavault AI
0.66%
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
94.56%
Scilex Holding Company stock logo
SCLX
Scilex
69.67%

Insider Ownership

CompanyInsider Ownership
Datavault AI Inc. stock logo
DVLT
Datavault AI
7.70%
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
6.50%
Scilex Holding Company stock logo
SCLX
Scilex
4.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Datavault AI Inc. stock logo
DVLT
Datavault AI
40949.73 million876.60 millionN/A
Nature's Miracle Holding Inc. stock logo
NMHI
Nature's Miracle
12837.64 million1.07 millionN/A
Scilex Holding Company stock logo
SCLX
Scilex
808.49 million8.11 millionNo Data

Recent News About These Companies

Scilex (SCLX) to Post Quarterly Earnings on Wednesday
Scilex Holding Company (NASDAQ: SCLX) - Share Price and Research
Scilex Holding Company

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Datavault AI stock logo

Datavault AI NASDAQ:DVLT

$0.28 -0.02 (-5.79%)
As of 04:00 PM Eastern

Datavault AI Inc., a data sciences technology company, owns and operates data management and supercomputer platforms. It offers data technology and software solutions. The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025. Datavault AI Inc. was incorporated in 2010 and is headquartered in Beaverton, Oregon.

Nature's Miracle stock logo

Nature's Miracle NASDAQ:NMHI

$0.0007 +0.00 (+16.67%)
As of 02:00 PM Eastern

Nature's Miracle Holding Inc., an agriculture technology company, provides lighting and grow media products to growers in the controlled environment agriculture industry in the United States and Canada. The company offers LED fixtures; high pressure sodium and ceramic metal halide fixtures; and electronic ballasts and control boxes. It also designs, builds, and operates various indoor growing settings, including greenhouse and indoor-growing spaces. The company sells its products directly to wholesale CEA distributors. Nature's Miracle Holding Inc. is headquartered in Ontario, California.

Scilex stock logo

Scilex NASDAQ:SCLX

$5.43 -0.14 (-2.51%)
As of 04:00 PM Eastern

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California.